RepAIR1NCT07431112
A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
Version history last read from ClinicalTrials.gov on Oct 24, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.
All 9 versions: 9 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Trial sites expanded: 12 → 15 locations
- Notable Eligibility criteria expanded, about 40 words
- Trial sites expanded: 8 → 12 locations
- Minor Study sites: 6 to 8v7
- Minor Study sites: 4 to 6v6
- Minor Study sites: 3 to 4v5
Show 3 earlier versionsHide 3 earlier versions
- Minor Start date: Feb 27, 2026 to Mar 17, 2026v4
- Minor Study sites: 2 to 3v3
Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 6 more changesShow less
- Eligibility criteria shortened, about 51 words
- Primary endpoints: 1 to 4
- Study sites: 1 to 2
- Start date changed from estimate of Feb 2026 to Feb 27, 2026
- Secondary endpoints revised (3)
- Study title shortened, about 2 words
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (3)
Arms and interventions
AIR-001 is an RNA-editing oligonucleotide in sterile preservative-free solution administered by subcutaneous (SC) injection as a single dose.
AIR-001 administered by SC injection as a single dose.
AIR-001 administered by SC injection as a single dose.
AIR-001 administered by SC injection, single dose.
AIR-001 is an RNA-editing oligonucleotide in sterile preservative-free solution administered by subcutaneous (SC) injection as multiple doses.
AIR-001 administered by SC injection as multiple doses.
AIR-001 administered by SC injection as multiple doses.
AIR-001 administered by SC injection as multiple doses.
AIR-001 administered by SC injection as multiple doses.
AIR-001 administered by SC injection as multiple doses.
Drugs: AIR-001 SAD dose level 1, AIR-001 SAD dose level 2, AIR-001 SAD dose level 3, AIR-001 SAD dose level 4, AIR-001 MD dose level 1, AIR-001 MD dose level 2, AIR-001 MD dose level 3, AIR-001 MD dose level 4, AIR-001 MD dose level 5, AIR-001 MD dose level 6
Sites
15 sites in 9 countries
United Kingdom 4, Germany 3, Georgia 2, Australia 1, Netherlands 1, New Zealand 1, Portugal 1, Spain 1, Sweden 1